Pavion Blue Capital, LLC Amgen Inc Transaction History

Pavion Blue Capital, LLC

  • $210 Million
  • Q4 2024

A detailed history of Pavion Blue Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pavion Blue Capital, LLC holds 3,095 shares of AMGN stock, worth $908,506. This represents 0.38% of its overall portfolio holdings.

Number of Shares
3,095
Previous 3,097 0.06%
Holding current value
$908,506
Previous $997,000 19.16%
% of portfolio
0.38%
Previous 0.47%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025
SELL
$258.78 - $328.31 $517 - $656
-2 Reduced 0.06%
3,095 $806,000
Q2 2024

Jul 15, 2024
SELL
$262.75 - $319.31 $9,721 - $11,814
-37 Reduced 1.18%
3,097 $967,000
Q1 2024

Apr 26, 2024
SELL
$268.87 - $324.56 $5,915 - $7,140
-22 Reduced 0.7%
3,134 $891,000
Q4 2023

Jan 24, 2024
SELL
$255.7 - $288.46 $28,127 - $31,730
-110 Reduced 3.37%
3,156 $908,000
Q3 2023

Nov 03, 2023
SELL
$218.65 - $271.46 $10,495 - $13,030
-48 Reduced 1.45%
3,266 $877,000
Q2 2023

Aug 02, 2023
BUY
$214.27 - $253.37 $428 - $506
2 Added 0.06%
3,314 $735,000
Q1 2023

May 02, 2023
SELL
$225.79 - $275.2 $4,967 - $6,054
-22 Reduced 0.66%
3,312 $800,000
Q4 2022

Feb 07, 2023
BUY
$229.03 - $291.01 $458 - $582
2 Added 0.06%
3,334 $875,000
Q3 2022

Nov 03, 2022
SELL
$224.46 - $253.15 $6,509 - $7,341
-29 Reduced 0.86%
3,332 $751,000
Q2 2022

Aug 02, 2022
BUY
$230.71 - $256.74 $5,998 - $6,675
26 Added 0.78%
3,361 $818,000
Q1 2022

May 05, 2022
BUY
$219.27 - $242.57 $438 - $485
2 Added 0.06%
3,335 $806,000
Q4 2021

Jan 28, 2022
BUY
$198.88 - $227.6 $79,552 - $91,040
400 Added 13.64%
3,333 $750,000
Q4 2021

Jan 26, 2022
SELL
$198.88 - $227.6 $109,384 - $125,180
-550 Reduced 15.79%
2,933 $660,000
Q3 2021

Nov 16, 2021
BUY
$212.27 - $248.7 $84,908 - $99,480
400 Added 12.97%
3,483 $741,000
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $84,695 - $99,231
-399 Reduced 11.46%
3,083 $656,000
Q2 2021

Aug 10, 2021
SELL
$233.58 - $259.14 $32,467 - $36,020
-139 Reduced 3.84%
3,482 $849,000
Q1 2021

May 10, 2021
SELL
$221.91 - $258.6 $19,749 - $23,015
-89 Reduced 2.4%
3,621 $901,000
Q4 2020

Feb 04, 2021
SELL
$216.38 - $257.67 $21,854 - $26,024
-101 Reduced 2.65%
3,710 $853,000
Q3 2020

Nov 02, 2020
BUY
$234.65 - $260.95 $274,071 - $304,789
1,168 Added 44.19%
3,811 $969,000
Q1 2020

May 11, 2020
BUY
$182.24 - $241.7 $236,547 - $313,726
1,298 Added 96.51%
2,643 $536,000
Q4 2019

Jan 30, 2020
BUY
$189.21 - $243.2 $254,487 - $327,104
1,345 New
1,345 $324,000

Others Institutions Holding AMGN

# of Institutions
3,095
Shares Held
405M
Call Options Held
7.57M
Put Options Held
7.12M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pavion Blue Capital, LLC Portfolio

Follow Pavion Blue Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pavion Blue Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pavion Blue Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email